Monday on the RealClearPolitics podcast, Tom Bevan, Andrew Walworth, and Carl Cannon discussed the return of celebrity ...
Sanofi’s LEAP2MONO phase 3 study of venglustat to treat type 3 Gaucher disease meets all primary endpoints: Paris Tuesday, February 3, 2026, 13:00 Hrs [IST] Positive results fro ...
Cystinosis requires lifelong cystine-depleting therapy; however, currently approved cysteamine products, Cystagon® and Procysbi®, are associated with frequent dosing, gastrointestinal intolerance, and ...
Jacobin on MSNOpinion
Four lessons from the UAW’s turn toward class struggle
Shawn Fain won the runoff to be president of the United Auto Workers (UAW) in March 2023, and the union he was elected to ...
Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease. In the LEAP2MONO phase 3 study, venglustat, dosed orally once daily, demonstrated cli ...
As the 250th anniversary of our independence approaches, let us linger over the most important sentence that James Madison ever wrote, and the most relevant to the current moment. “The accumulation of ...
Cultivating greater patience can help you deal with everyday difficulties and frustrations. These strategies may be helpful.
Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results